Stay updated on Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A site footer revision/version indicator was updated from “v3.5.2” to “v3.5.3,” reflecting a website release rather than any change to the study details.
    Difference
    0.0%
    Check dated 2026-04-24T06:17:30.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added related topics 'Multiple myeloma' and 'MedlinePlus Genetics', and updated the revision tag to v3.5.2 (removing v3.5.0).
    Difference
    0.1%
    Check dated 2026-04-17T02:51:00.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Deleted content includes the disease term 'Multiple myeloma' and the related topic 'MedlinePlus Genetics', reducing linked topics and context on the study page.
    Difference
    0.1%
    Check dated 2026-04-09T21:46:57.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics to the study page to improve context and access to relevant resources.
    Difference
    0.1%
    Check dated 2026-03-26T11:48:35.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Removed the term 'Multiple Myeloma' and a related topic, and added a new page revision label 'Revision: v3.5.0' (replacing 'Revision: v3.4.3').
    Difference
    0.1%
    Check dated 2026-03-19T06:02:07.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' as a related topic and linked MedlinePlus Genetics. Updated the site revision from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:14:07.000Z thumbnail image

Stay in the know with updates to Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page.